Transient Ischemic Attack clinical trials at University of California Health
3 in progress, 1 open to eligible people
Sleep for Stroke Management and Recovery Trial
open to eligible people ages 18 years and up
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
at UC Davis UC Irvine UCLA UCSD UCSF
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
Sorry, in progress, not accepting new patients
The purpose of this clinical study is to determine whether the addition of an oral Factor XIa Inhibitor to Aspirin and Clopidogrel is more effective than standard therapy in secondary stroke prevention.
at UC Davis UCLA
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Sorry, not yet accepting patients
An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
at UCLA
Our lead scientists for Transient Ischemic Attack research studies include Dawn Meyer, PhD Kwan Ng, MD Neal Rao, MD Wade Smith, MD, PhD Sara Stern Nezer, MD David Liebeskind Alon Avidan, MD.
Last updated: